COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR SECOND QUARTER FINANCIAL RESULTS

Company Overview - CollPlant Biotechnologies is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs, tissue repair, and medical aesthetics [2] - The company's products are based on rhCollagen (recombinant human collagen) produced using proprietary plant-based genetic engineering technology [2] Recent Developments - CollPlant will report its financial results for the second quarter on August 20, 2025, before the opening of U.S. financial markets [1] - In 2021, CollPlant entered into a development and global commercialization agreement for dermal and soft tissue fillers with Allergan, a leader in the dermal filler market [3]